Multiple muscle wasting-related transcription factors are acetylated in dexamethasone-treated muscle cells

Biochemistry and Cell Biology

Volumn 90, Issue 2, 2012, Pages 200-208

  Chamberlain, Wei ^a   Gonnella, Patricia ^a   Alamdari, Nima ^a   Aversa, Zaira ^a   Hasselgren, Per Olof ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

Acetylation; Glucocorticoids; Muscle atrophy; Posttranslational modifications; Transcription factors

Indexed keywords

ACETYLATION; HORMONES; PROTEINS; TRANSCRIPTION; TRANSCRIPTION FACTORS;

CELLULAR PROTEINS; GENE TRANSCRIPTIONS; GLUCOCORTICOIDS; HISTONE ACETYLTRANSFERASE P300; INDUCED TRANSCRIPTION; MUSCLE ATROPHY; POST-TRANSLATIONAL MODIFICATIONS; TARGETING MOLECULES;

MUSCLE;

ATROGIN 1; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; DEXAMETHASONE; E1A ASSOCIATED P300 PROTEIN; MUSCLE RING FINGER 1 PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; IN VITRO STUDY; MUSCLE ATROPHY; MUSCLE CELL; MYOTUBE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

EID: 84862750591     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/o11-082     Document Type: Article

References (51)

1. Alamdari N. Smith I.J. Aversa Z. Hasselgren P.O. 2010. Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299 (2): R509-R520. 10.1152/ajpregu.00858.2009 20538901
2. An M.R. Hsieh C.C. Resiner P.D. Rabek J.P. Scott S.G. Kuninger D.T. Papaconstantinou J. 1996. Evidence for posttranslational regulation of C/EBPα and C/EBPβ isoform expression during the lipopolysacharide- mediated acute-phase response. Mol. Cell. Biol. 16 (5): 2295-2306.
3. An B.S. Tavera-Mendoza L.E. Dimitrov V. Wang X. Calderon M.R. Wang H.J. White J.H. 2010. Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor. Mol. Cell. Biol. 30 (20): 4890-4900. 10.1128/MCB.00180-10 20733005
4. Aoki M. Jiang H. Vogt P.K. 2004. Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3K and Akt oncoproteins. Proc. Natl. Acad. Sci. U.S.A. 101 (37): 13613-13617. 10.1073/pnas.0405454101 15342912
5. Brunet A. Sweeney L.B. Sturgill J.F. Chua K.F. Greer P.L. Lin Y. et al. 2004. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science, 303 (5666): 2011-2015. 10.1126/science.1094637 14976264
6. Buerki C. Rothgiesser K.M. Valovka T. Owen H.R. Rehrauer H. Fey M. et al. 2008. Functional relevance of novel p300-mediated lysine 314 and 315 acetylation of RelA/p65. Nucleic Acids Res. 36 (5): 1665-1680. 10.1093/nar/gkn003 18263619
7. Cai D. Frantz J.D. Tawa Jr. N.E. Melendez P.A. Lidow H.G.W. Hasselgren P.O. et al. 2004. Iκκβ/NF-κB activation causes severe muscle wasting in mice. Cell, 119 (2): 285-298. 10.1016/j.cell.2004.09.027 15479644
8. Ceseña T.I. Cardinaux J.R. Kwok R. Schwartz J. 2007. CCAAT/enhancer-binding protein (C/EBP)β is acetylated at multiple lysines. Acetylation of C/EBPβ at lysine 39 modulates its ability to activate transcription. J. Biol. Chem. 282 (2): 956-967. 10.1074/jbc.M511451200 17110376
9. Ceseña T.I. Cui T.X. Subranamian L. Fulton C.T. Iñiguez-Lluhí J.A. Kwok R.P. Schwartz J. 2008. Acetylation and deacetylation regulate CCAAT/enhancer-binding protein β at K39 inmediateing gene transcription. Mol. Cell. Endocrinol. 289 (1-2): 94-101. 10.1016/j.mce.2008.03.009 18486321
10. Chen L.F. Greene W.C. 2003. Regulation of distinct biological activities of the NF-kB transcription factor complex by acetylation. J. Mol. Med. (Berl.), 81 (9): 549-557. 10.1007/s00109-003-0469-0
11. Choudhary C. Kumar C. Gnad F. Nielsen M.L. Rehman M. Walther T.C. et al. 2009. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science, 325 (5942): 834-840. 10.1126/science.1175371 19608861
12. Daitoku H. Hatta M. Matsuzaki H. Aratani S. Ohshima T. Miyagishi M. et al. 2004. Silent information regulator 2 potentiates FOXO1-mediated transcription through its deaceylase activity. Proc. Natl. Acad. Sci. U.S.A. 101 (27): 10042-10047. 10.1073/pnas.0400593101 15220471
13. Descombes P. Schibler U. 1991. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell, 67 (3): 569-579. 10.1016/0092-8674(91)90531-3 1934061
14. Fukuoka M. Daitoku H. Hatta M. Matsuzaki H. Umemura S. Fukamizu A. 2003. Negative regulation of forkhead transcription factor AFX (FOXO4) by CBP-induced acetylation. Int. J. Mol. Med. 12 (4): 503-508. 12964026
15. Furuyama T. Yamashita H. Kitayama K. Higami Y. Shimokawa I. Mori N. 2002. Effects of aging and caloric restriction on the gene expression of Foxo 1, 3, and 4 (FKHR, FKHRL1, and AFX) in the rat skeletal muscles. Microsc. Res. Tech. 59 (4): 331-334. 10.1002/jemt.10213 12424797
16. Gonnella P. Alamdari N. Tizio S. Aversa Z. Petkova V. Hasselgren P.O. 2011. C/EBPβ regulates dexamethasone-induced muscle cell atrophy and expression of atrogin-1 and MuRF1. J. Cell. Biochem. 112 (7): 1737-1748. 10.1002/jcb.23093 21381078
17. Hariharan N. Maejima Y. Nakae J. Paik J. DePinho R.A. Sadoshima J. 2010. Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes. Circ. Res. 107 (12): 1470-1482. 10.1161/CIRCRESAHA.110.227371 20947830
18. Hasselgren P.O. 2007. Ubiquitination, phosphorylation, and acetylation -triple threat in muscle wasting. J. Cell. Physiol. 213 (3): 679-689. 10.1002/jcp.21190 17657723
19. Hasselgren P.O. Menconi M.J. Fareed M.U. Yang H. Wei W. Evenson A.R. 2005. Novel aspects on the regulation of muscle wasting in sepsis. Int. J. Biochem. Cell Biol. 37 (10): 2156-2168. 10.1016/j.biocel.2005.01.017 16125115
20. Hasselgren P.O. Alamdari N. Aversa Z. Gonnella P. Smith I.J. Tizio S. 2010. Corticosteroids and muscle wasting -role of transcription factors, nuclear cofactors, and hyperacetylation. Curr. Opin. Clin. Nutr. Metab. Care, 13 (4): 423-428. 10.1097/MCO.0b013e32833a5107 20473154
21. Hermoso M.A. Cidlowski J.A. 2003. Putting the brake on inflammatory responses: the role of glucocorticoids. IUBMB Life, 55 (9): 497-504. 10.1080/15216540310001642072 14658755
22. Kamei Y. Miura S. Suzuki M. Kai Y. Mizukami J. Taniguchi T. et al. 2004. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, downregulated type1 (slow twitch/red muscle) fiber genes, and impaired glycemic control. J. Biol. Chem. 279 (39): 41114-41123. 10.1074/jbc.M400674200 15272020
23. Lecker S.H. Jagoe R.T. Gilbert A. Gomes M. Baracos V. Bailey J. et al. 2004. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 18 (1): 39-51. 10.1096/fj.03-0610com 14718385
24. Lecker S.H. Goldberg A.L. Mitch W.E. 2006. Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J. Am. Soc. Nephrol. 17 (7): 1807-1819. 10.1681/ASN.2006010083 16738015
25. Menconi M. Gonnella P. Petkova V. Lecker S. Hasselgren P.O. 2008. Dexamethasone and corticosterone induce similar, but not identical muscle wasting responses in cultured L6 and C2C12 myotubes. J. Cell. Biochem. 105 (2): 353-364. 10.1002/jcb.21833 18615595
26. Motta M.C. Divecha N. Lemieux M. Kamel C. Chen D. Gu W. et al. 2004. Mammalian SIRT1 represses forkhead transcription factors. Cell, 116 (4): 551-563. 10.1016/S0092-8674(04)00126-6 14980222
27. Penner C.G. Gang G. Wray C. Fischer J.E. Hasselgren P.O. 2001. The transcription factors NF-κB and AP-1 are differentially regulated in skeletal muscle during sepsis. Biochem. Biophys. Res. Commun. 281 (5): 1331-1336. 10.1006/bbrc.2001.4497 11243882
28. Penner G. Gang G. Sun X. Wray C. Hasselgren P.O. 2002. C/EBP DNA binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282 (2): R439-R444. 11792653
29. Perrot V. Rechler M.M. 2005. The coactivator p300 directly acetylates the forkhead transcription factor Foxo1 and stimulates Foxo1-induced transcription. Mol. Endocrinol. 19 (9): 2283-2298. 10.1210/me.2004-0292 15890677
30. Sandri M. 2010. Autophagy in health and disease. 3. Involvement of autophagy in muscle atrophy. Am. J. Physiol. Cell Physiol. 298 (6): C1291-C1297. 10.1152/ajpcell.00531.2009 20089936
31. Sandri M. Sandri C. Gilbert A. Skurk C. Calabria E. Picard A. et al. 2004. FOXO transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell, 117 (3): 399-412. 10.1016/S0092-8674(04)00400-3 15109499
32. Senf S.M. Sandesara P.B. Reed S.A. Judge A.R. 2011. p300 acetyltransferase activity differentially regulates the localization and activity of the FOXO homologues in skeletal muscle. Am. J. Physiol. Cell Physiol. 300 (6): C1490-C1501. 10.1152/ajpcell.00255.2010 21389279
33. Schakman O. Gilson H. Thissen J.P. 2008. Mechanisms of glucocorticoid-induced myopathy. J. Endocrinol. 197 (1): 1-10. 10.1677/JOE-07-0606 18372227
34. Smith I.J. Alamdari N. O'Neal P. Gonnella P. Aversa Z. Hasselgren P.O. 2010. Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism. Int. J. Biochem. Cell Biol. 42 (5): 701-711. 10.1016/j.biocel.2010. 01.006 20079455
35. Sterner D.E. Berger S.L. 2000. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64 (2): 435-459. 10.1128/MMBR.64.2.435-459.2000 10839822
36. Svotelis A. Doyon G. Bernatchez G. Desilets A. Rivard N. Asselin C. 2005. IL-1β-dependent regulation of C/EBPδ transcriptional activity. Biochem. Biophys. Res. Commun. 328 (2): 461-470. 10.1016/j.bbrc.2005.01.002 15694370
37. Tisdale M.J. 2009. Mechanisms of cancer cachexia. Physiol. Rev. 89 (2): 381-410. 10.1152/physrev.00016.2008 19342610
38. Turgeon N. Valiquette C. Blais M. Routhier S. Seidman E.G. Asselin C. 2008. Regulation of C/EBPδ-dependent transactivation by histone deacetylase in intestinal epithelial cells. J. Cell. Biochem. 103 (5): 1573-1583. 10.1002/jcb.21544 17910034
39. van der Heide L.P. Hoekman M.F. Smidt M.P. 2004. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem. J. 380 (2): 297-309. 10.1042/BJ20040167 15005655
40. van der Heide L.P. Smidt M.P. 2005. Regulation of FoxO activity by CBP/p300-mediated acetylation. Trends Biochem. Sci. 30 (2): 81-86. 10.1016/j.tibs.2004.12.002 15691653
41. Van Gammeren D. Damrauer J.S. Jackman R.W. Kandarian S.C. 2009. The IkB kinases IKKα and IKKβ are necessary and sufficient for skeletal muscle atrophy. FASEB J. 23 (2): 362-370. 10.1096/fj.08-114249 18827022
42. Vo N. Goodman R.H. 2001. CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 276 (17): 13505-13508. 11279224
43. Wang H. Larris B. Peiris T.H. Zhang L. LeLay J. Gao Y. Greenbaum L.E. 2007. C/EBPβ activates E2F-regulated genes in vivo via recruitment of the coactivators CREB-binding protein/p300. J. Biol. Chem. 282 (34): 24679-24688. 10.1074/jbc.M705066200 17599912
44. Wei W. Yang H. Cao P. Menconi M.J. Chamberlain C. Petkova V. Hasselgren P.O. 2006. Degradation of C/EBPβ in cultured myotubes is calpain-dependant. J. Cell. Physiol. 208 (2): 386-398. 10.1002/jcp.20684 16646084
45. Welm A.L. Timchenko N.A. Darlington G.J. 1999. C/EBPα regulates generation of C/EBPβ isoforms through activation of specific proteolytic cleavage. Mol. Cell. Biol. 19 (3): 1695-1704. 10022857
46. Wiper-Bergeron N. Wu D. Pope L. Schild-Poulter C. Hache R.J.G. 2003. Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex. EMBO J. 22 (9): 2135-2145. 10.1093/emboj/cdg218 12727880
47. Wiper-Bergeron N. Salem H.A. Tomlinson J. Wu D. Haché R.J.G. 2007. Glucocorticoid-stimulated preadipocyte differentiation is mediated through acetylation of C/EBPβ by GCN5. Proc. Natl. Acad. Sci. U.S.A. 104 (8): 2703-2708. 10.1073/pnas.0607378104 17301242
48. Yang Y. Hou H. Haller E.M. Nicosia S.V. Bai W. 2005 a. Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation. EMBO J. 24 (5): 1021-1032. 10.1038/sj.emboj.7600570 15692560
49. Yang H. Mammen J. Wei W. Menconi M. Evenson A. Fareed M. et al. 2005 b. The expression and activity of C/EBPβ and δ are upregulated by dexamethasone in skeletal muscle. J. Cell. Physiol. 204 (1): 219-226. 10.1002/jcp.20278 15669083
50. Yang H. Menconi M. Wei W. Petkova V. Hasselgren P.O. 2005 c. Dexamathasone upregulates the expression of the nuclear cofactor p300 and its interaction with C/EBPβ in cultured myotubes. J. Cell. Biochem. 94 (5): 1058-1067. 10.1002/jcb.20371 15669015
51. Yang H. Wei W. Menconi M. Hasselgren P.O. 2007. Dexamethasone-induced protein degradation in cultured myotubes is p300/HAT-dependent. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292 (1): R337-R344. 16973938